Coventry, United Kingdom

David Haddleton

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Haddleton

Introduction

David Haddleton is a notable inventor based in Coventry, GB. He has made significant contributions to the field of drug delivery systems, holding two patents that showcase his innovative approach to adhesive compositions.

Latest Patents

Haddleton's latest patents include a novel composition for drug delivery patches. This invention relates to compositions comprising urea and amine functionalized silyl containing polymers, which, when combined with tackifying resins, serve as pressure-sensitive adhesives. These compositions can be synthesized with less difficulty compared to urethane analogues and are compatible with a wide array of different drugs. Another patent focuses on a drug delivery composition containing silyl polymers, which, along with a tackifying resin, forms an adhesive capable of storing and delivering drugs to the skin. This composition is typically formed into a patch that exhibits excellent adhesion to the skin, even when drugs and other additives are incorporated.

Career Highlights

Throughout his career, David Haddleton has worked with prominent companies such as Medherant Limited and Bostik SA. His work has significantly advanced the field of drug delivery systems, particularly in the development of effective adhesive compositions.

Collaborations

Haddleton has collaborated with notable individuals in his field, including Gabit Nurumbetov and Andrew Ross. These collaborations have contributed to the success of his innovative projects.

Conclusion

David Haddleton's contributions to the field of drug delivery systems through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in adhesive technologies and drug delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…